Skip to main content

What the FDA labels say about taking them together

Ertapenem and probenecid

Ertapenem's FDA label of February 4, 2026 names probenecid in its drug interactions section; the probenecid label PlainMeds reads does not name ertapenem. The ertapenem label: “DRUG INTERACTIONS Co-administration with probenecid inhibits the renal excretion of ertapenem and is therefore not recommended. The concomitant use of ertapenem and valproic acid/divalproex sodium is generally not …”

Check it at the source: the ertapenem FDA label on DailyMed (effective February 4, 2026, Merck Sharp & Dohme LLC); the probenecid FDA label on DailyMed (effective January 5, 2021, Lannett Company, Inc.).

What does the ertapenem label say about probenecid?

Ertapenem label, drug interactions

DRUG INTERACTIONS Co-administration with probenecid inhibits the renal excretion of ertapenem and is therefore not recommended. ( 7.1 ) The concomitant use of ertapenem and valproic acid/divalproex sodium is generally not recommended.

Source: FDA drug label (INVANZ), Merck Sharp & Dohme LLC, effective February 4, 2026 (SPL set 33f3b99b-fa82-42e0-26bf-f49891ae3d22), via openFDA; the full label on DailyMed

What does the probenecid label say about ertapenem?

Probenecid's label (effective January 5, 2021) does not name ertapenem in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Probenecid), Lannett Company, Inc., effective January 5, 2021 (SPL set ab497fd8-00c3-4364-b003-b39d21fbdf38), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

15Ertapenem generic labelers
6Probenecid generic labelers
ErtapenemProbenecid
Labeled forUrinary tract infectionsGout
Boxed warningNoNo
Pharmacy cost (NADAC)$26.63 per vial 1 gram vial$0.636 per tablet 500 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?